Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1663-1672

  Kaira, Kyoichi ^a   Ohde, Yasuhisa ^a   Nakagawa, Kazuo ^a   Okumura, Takehiro ^a   Murakami, Haruyasu ^a   Takahashi, Toshiaki ^a   Kondo, Haruhiko ^a   Nakajima, Takashi ^a   Endo, Masahiro ^a   Yamamoto, Nobuyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Adenocarcinoma; DPD; NSCLC; OPRT; Prognosis; TS

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; DIHYDROPYRIMIDINE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; OROTATE PHOSPHORIBOSYLTRANSFERASE; PACLITAXEL; PLATINUM DERIVATIVE; PROTEIN KINASE B; PROTEIN P53; TEGAFUR; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR PARAMETERS; CELL CYCLE REGULATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVESSEL DENSITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; OROTATE PHOSPHORIBOSYLTRANSFERASE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84867250442     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0069-8     Document Type: Article

References (30)

1. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of prognosis. Chest. 2002;122:1037-57.
2. Danenberg PV. Thymidylate synthase: a target enzyme in cancer chemotherapy. Biochim Biophys Acta. 1997;473:73-92.
3. Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol. 1996;14:1048-54.
4. Nakano J, et al. Evaluation of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT. Br J Cancer. 2006;95:607-15.
5. Nakagawa T, et al. Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC). Lung Cancer. 2004;43:145-9.
6. Ceppi P, et al. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer. 2006;107:1589-96.
7. Hashimoto H, et al. Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung. Cancer. 2006;106:1595-601.
8. Atkin GK, et al. The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery. Br J Cancer. 2006;95:928-33.
9. Okabe T, et al. Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase. Mol Cancer Ther. 2008;7:599-606.
10. Mountain CF. Revision in the international system for staging lung cancer. Chest. 1997;11:1710-7.
11. Kaira K, et al. Biologic correlation of 2-[18F]-fluoro-2-deoxy-Dglucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol. 2010;28:3746-53.
12. Shirota Y, et al. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol. 2001;19:4298-304.
13. Lenz H, et al. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol. 1995;14:176-82.
14. Ceppi P, et al. Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors. Clin Cancer Res. 2008;14:1059-64.
15. Ibe T, et al. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes. J Surg Oncol. 2010;102:11-7.
16. Griffiths L, et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res. 1997;57:570-2.
17. Vleugel MM, et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer. J Clin Pathol. 2005;58:172-7.
18. Elson DA, et al. Coordinate up-regulation of hypoxia inducible factor (HIF)-1a and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing 1. Cancer Res. 2000;60:6189-95.
19. Ryan HE, et al. Hypoxia-inducible factor-1a is a positive factor in solid tumor growth. Cancer Res. 2000;60:4010-5.
20. Kaira K, et al. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci. 2009;100:753-8.
21. Hamada C, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol. 2005;23:4999-5007.
22. Ishihama H, et al. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung. Jpn J Clin Oncol. 2009;39:33-6.
23. Harada K, Kawashima Y, Yoshida H, Sato M. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1. Oncol Rep. 2006;15:1417-23.
24. Lee S, et al. Thymidylate synthase, thymidine phosphorylase, and excision repair-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma. Br J Cancer. 2010;7:845-51.
25. Shirasaka T, et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996;7:548-57.
26. Kawahara M, et al. Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer. Br J Cancer. 2001;85:939-43.
27. Yamamoto N, et al. Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type. Anticancer Res. 2010;30:2985-90.
28. Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. Int J Mol Med. 2008;22:709-16.
29. Takeda M, Okamoto I, Hirabayashi N, Kitano M, Nakagawa K. Thymidylate synthase and dihydropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer. Lung Cancer. 2011;73:103-9.
30. Sun JM, Han J, Ahn JS, Park K, Ahn MJ. Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy. J Thorac Oncol. 2011;6:1392-9.